Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Equity (2016 - 2025)

ImmunityBio (IBRX) has disclosed Return on Equity for 11 consecutive years, with 0.69% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 1.0% to 0.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.71% for FY2025, 6.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.69% at ImmunityBio, up from 0.64% in the prior quarter.
  • The five-year high for Return on Equity was 1.88% in Q3 2021, with the low at 0.63% in Q2 2025.
  • Average Return on Equity over 5 years is 1.05%, with a median of 0.91% recorded in 2023.
  • The sharpest move saw Return on Equity plummeted -8046bps in 2021, then rose 22bps in 2023.
  • Over 5 years, Return on Equity stood at 1.61% in 2021, then tumbled by -41bps to 0.95% in 2022, then increased by 23bps to 1.17% in 2023, then tumbled by -43bps to 0.67% in 2024, then increased by 2bps to 0.69% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.69%, 0.64%, and 0.63% for Q4 2025, Q3 2025, and Q2 2025 respectively.